Profiel
D.
Grayson Allen is currently the Chief Operating Officer, CFO & Director at RevBio, Inc. He previously worked as a Principal at Citizens Capital Markets, Inc. Allen is a graduate of Dartmouth College.
Actieve functies van D. Grayson Allen
| Bedrijven | Functie | Begin |
|---|---|---|
RevBio, Inc.
RevBio, Inc. Medical SpecialtiesHealth Technology Manufactures dental, cranial, trauma,spinal and animal health treatment medical devices | Financieel Directeur/CFO | - |
Eerdere bekende functies van D. Grayson Allen
| Bedrijven | Functie | Einde |
|---|---|---|
Citizens Capital Markets, Inc.
Citizens Capital Markets, Inc. Investment ManagersFinance Citizens Capital Markets invests in companies located in the United States, with revenues of USD 15 - 250 million and an EBITDA of USD 3 million for mezzanine investments. The firm focuses on sectors such as business services, technology, software, consumer products, distributors and manufacturers. It participates in mezzanine, growth, buyouts and recapitalization capital requirements with an investment size of USD 3 - 15 million for subordinated debt investments and USD 1 - 3 million for growth equity investments. It makes co-investments and also takes a seat on the board of directors. | Corporate Officer/Principal | - |
Opleiding van D. Grayson Allen
Ervaring
Beklede functies
Actief
Inactief
Beursgenoteerde bedrijven
Bedrijven in privébezit
Connecties
Eerstegraads connecties
Bedrijven verbonden in de eerste graad
Man
Vrouw
Besturend
Uitvoerend
Verwante bedrijven
| Bedrijven in privébezit | 3 |
|---|---|
Dartmouth College
Dartmouth College Other Consumer ServicesConsumer Services Functions as a College/University | Consumer Services |
Citizens Capital Markets, Inc.
Citizens Capital Markets, Inc. Investment ManagersFinance Citizens Capital Markets invests in companies located in the United States, with revenues of USD 15 - 250 million and an EBITDA of USD 3 million for mezzanine investments. The firm focuses on sectors such as business services, technology, software, consumer products, distributors and manufacturers. It participates in mezzanine, growth, buyouts and recapitalization capital requirements with an investment size of USD 3 - 15 million for subordinated debt investments and USD 1 - 3 million for growth equity investments. It makes co-investments and also takes a seat on the board of directors. | Finance |
RevBio, Inc.
RevBio, Inc. Medical SpecialtiesHealth Technology Manufactures dental, cranial, trauma,spinal and animal health treatment medical devices | Health Technology |
















